Volume 24, Number 2—February 2018
Multiplex PCR−Based Next-Generation Sequencing and Global Diversity of Seoul Virus in Humans and Rats
Views: Views equals page views plus PDF downloadsMetric Details
Highlight and copy the desired format.
|EID||Kim W, No J, Lee S, Song D, Lee D, Kim J, et al. Multiplex PCR−Based Next-Generation Sequencing and Global Diversity of Seoul Virus in Humans and Rats. Emerg Infect Dis. 2018;24(2):249-257. https://dx.doi.org/10.3201/eid2402.171216|
|AMA||Kim W, No J, Lee S, et al. Multiplex PCR−Based Next-Generation Sequencing and Global Diversity of Seoul Virus in Humans and Rats. Emerging Infectious Diseases. 2018;24(2):249-257. doi:10.3201/eid2402.171216.|
|APA||Kim, W., No, J., Lee, S., Song, D., Lee, D., Kim, J....Song, J. (2018). Multiplex PCR−Based Next-Generation Sequencing and Global Diversity of Seoul Virus in Humans and Rats. Emerging Infectious Diseases, 24(2), 249-257. https://dx.doi.org/10.3201/eid2402.171216.|
Seoul virus (SEOV) poses a worldwide public health threat. This virus, which is harbored by Rattus norvegicus and R. rattus rats, is the causative agent of hemorrhagic fever with renal syndrome (HFRS) in humans, which has been reported in Asia, Europe, the Americas, and Africa. Defining SEOV genome sequences plays a critical role in development of preventive and therapeutic strategies against the unique worldwide hantavirus. We applied multiplex PCR–based next-generation sequencing to obtain SEOV genome sequences from clinical and reservoir host specimens. Epidemiologic surveillance of R. norvegicus rats in South Korea during 2000–2016 demonstrated that the serologic prevalence of enzootic SEOV infections was not significant on the basis of sex, weight (age), and season. Viral loads of SEOV in rats showed wide dissemination in tissues and dynamic circulation among populations. Phylogenetic analyses showed the global diversity of SEOV and possible genomic configuration of genetic exchanges.
Hantaviruses (order Bunyavirales, family Hantaviridae, genus Orthohantavirus) pose a worldwide public health threat and are the causative agents of hemorrhagic fever with renal syndrome (HFRS) in Eurasia and hantavirus pulmonary syndrome in the Americas (1). HFRS is caused mainly by Old World hantaviruses, such as Hantaan virus (HTNV), Seoul virus (SEOV), Dobrava–Belgrade virus, and Puumala virus, that are transmitted to humans by inhalation of dust contaminated with rodent excreta (saliva, urine, and feces) or bite by an infected rodent. Annually, 150,000 cases of HFRS are reported (case-fatality rate range <1%–15%) (2). Clinical signs and symptoms include headache, myalgia, abdominal and back pain, nausea, vomiting, diarrhea, proteinuria, thrombocytopenia, hemorrhage, and renal failure (3). The typical disease course consists of 5 phases: febrile, hypotensive, oliguric, diuretic, and convalescent: the phases vary in length from several hours to several days. A difficulty in diagnosis is the extensive incubation period from the time of exposure to the onset of symptoms, which might be as long as 50 days. There are no effective vaccines or antiviral agents against hantavirus infection.
SEOV has a negative-sense, single-stranded, tripartite RNA genome (4). The large (L) segment encodes an RNA-dependent RNA polymerase, the medium (M) segment encodes 2 membrane glycoproteins (Gn and Gc), and the small (S) segment encodes a nucleoprotein. Brown rats (Rattus norvegicus) and black rats (R. rattus) are the primary reservoir hosts of SEOV and have a worldwide distribution (5,6).
SEOV infections have been reported in Asia, Europe, the Americas, and Africa (7–12). HFRS caused by SEOV is responsible for 25% of clinical cases and is a mild form with a case-fatality rate of <1% in Asia (13). Recently, an outbreak of SEOV-induced HFRS was reported in the United Kingdom among rat owners, breeders, and distributors of the pet animal market (14). In the United States, outbreaks of SEOV infections occurred in 11 states in 2017; there were 17 confirmed SEOV-infected patients (15,16). SEOV was identified in New York, New York, and is considered an urban public health threat (17).
Whole-genome sequencing of SEOV is a prerequisite for tracking SEOV infections and evaluating disease risks for development and implementation of preventive and therapeutic strategies. Acquisition of viral genome sequences plays a critical role in surveillance, identification, and risk mitigation of outbreaks of virus infection (18). Next-generation sequencing (NGS) is a potent tool for defining virus genome sequences. However, an obstacle for obtaining virus genomic information is ultra-low virus RNA loads in the clinical specimens. To enrich the low amount of viral RNA, we developed a multiplex PCR–based NGS that showed high coverage of HTNV genome sequences from HFRS patients (19).
In this study, we collected 1,269 R. norvegicus rats in an urban HFRS-endemic area in South Korea during 2000–2016. We report a robust strategy for whole-genome sequencing of SEOV and provide useful insights into epidemiologic characteristics and phylogeographic diversity of a unique worldwide hantavirus.
Human samples were provided after informed consent was obtained. The study was approved and conducted in accordance with ethicals guidelines for the Korea University Institutional Animal Care and Use Committee. Live trapping of rats at US military training sites and installations was approved by US Forces Korea in accordance with regulation 40–1 (Prevention, Surveillance, and Treatment of Hemorrhagic Fever with Renal Syndrome). Rats were humanely killed by cardiac puncture, and tissues were collected under isoflurane anesthesia in accordance with procedures approved by Korea University Institutional Animal Care and Use Committee protocol #2010–212.
We tested retrospective HFRS patient serum samples obtained from the Korea Bank for Pathogenic Viruses (Seoul, South Korea). We collected R. norvegicus rats during 2000–2016 by using collapsible live-capture traps (Tomahawk Live Trap Co., Hazelhurst, WI, USA, and H.B. Sherman, Tallahassee, FL, USA). Traps were set at intervals of 1–2 m and examined early the next morning over a 1–2-day period at US Army training sites. For the US Army Garrison in Seoul, we used baited live capture traps (Tomahawk Live Trap Co.) or glue boards. Captured rats were submitted to the 5th Medical Detachment/Medical Command Activity–Korea, US Army Garrison (Yongsan, Seoul), and then transported to the College of Medicine, Korea University (Seoul), where they were held in a Biosafety Level 3 laboratory until processing. Live rats were humanely killed by cardiac puncture under isoflurane anesthesia and identified to species by using morphologic criteria and PCR, when required. Serum, lung, spleen, kidney, and liver tissues were collected aseptically and frozen at −70°C until used.
Indirect Immunofluorescence Antibody Test
We used an indirect immunofluorescence antibody (IFA) test for serum samples from HFRS patients and live rats. We initially diluted samples 1:32 in phosphate-buffered saline and then tested them for IgG against SEOV. We applied diluted serum samples to slides containing SEOV-infected Vero E6 cells fixed with acetone and incubated wells at 37°C for 30 min. The slides were washed, fluorescein isothiocyanate–conjugated goat antibody to human and rat IgG (ICN Pharmaceuticals, Laval, Quebec, Canada) was added, and slides were incubated at 37°C for 30 min. We then washed the slides again and examined them for virus-specific fluorescence by using a fluorescent microscope (Axio Scope; Zeiss, Berlin, Germany).
Real-Time Quantitative PCR
We performed real-time quantitative PCR (qPCR) for total RNA by using the high-capacity RNA-to-cDNA Kit (Applied Biosystems, Carlsbad, CA, USA) in a 10-μL reaction mixture containing 1 µg of total RNA. We used an SYBR Green PCR Master Mix (Applied Biosystems) in a StepOne Real-Time PCR System (Applied Biosystems). We performed reactions at 95°C for 10 min, followed by 45 cycles at 95°C for 15 s, and then 1 cycle at 60°C for 1 min. Primer sequences specific for SEOV S segments were SEOV-S719F: 5′-TGGCACTAGCAAAAGACTGG-3′ and SEOV-S814R: 5′-CAGATAAACTCCCAGCAATAGGA-3′.
Reverse Transcription and Rapid Amplification of cDNA Ends PCR
We extracted total RNA from serum or lung tissues of seropositive samples by using TRI Reagent Solution (Ambion Inc., Austin, TX, USA). We synthesized cDNA by using the High Capacity RNA-to-cDNA Kit (Applied Biosystems) and random hexamer or OSM55 (5′-TAGTAGTAGACTCC-3′). For initial identification, we used oligonucleotide primers for SEOV L segment as described (20). To obtain the 3′ and 5′ termini genome sequences of SEOV, we performed rapid amplification of cDNA ends (RACE) PCR by using a 3′-Full RACE Core Set and a 5′-Full RACE Core Set (Takara Bio Inc., Kusatsu, Shiga, Japan), according to the manufacturer’s specifications. We purified PCR products by using the LaboPass PCR Purification Kit (Cosmo Genetech, Seoul, South Korea). We performed sequencing in both directions of each PCR product by using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) on an automated sequencer (Applied Biosystems).
Multiplex PCR–Based NGS
We designed multiplex PCR primers for SEOV L, M, and S segments and amplified cDNA by using primers (Technical Appendix 1) and primer mixtures and Solg 2× Uh-Taq PCR Smart Mix (Solgent, Daejeon, South Korea), according to the manufacturer’s instructions. We performed the first and second enrichments in a 25-μL reaction mixture containing 12.5 μL of 2× Uh pre-mix, 1 μL of cDNA template, 10 μL of primer mixture, and 1.5 μL of distilled water. Initial denaturation was at 95°C for 15 min, followed by 40 cycles or 25 cycles at 95°C for 20 s, 50°C for 40 s, and 72°C for 1 min, and a final elongation at 72°C for 3 min.
We prepared multiplex PCR products by using the TruSeq Nano DNA LT Sample Preparation Kit (Illumina, San Diego, CA, USA) according to the manufacturer’s instructions. We mechanically sheared samples by using an M220 focused ultrasonicator (Covaris, Woburn, MA, USA). The cDNA amplicon was size-selected, A-tailed, ligated with indexes and adaptors, and enriched. We sequenced libraries by using the MiSeq benchtop sequencer (Illumina) with 2 × 150 bp and a MiSeq reagent V2 (Illumina). We imported and analyzed Illumina FASTQ files by using EDGE (21).
We aligned and edited virus genome sequences by using the multiple sequence alignment with high accuracy and high throughput algorithm (22). We generated phylogenetic trees by using the maximum-likelihood method in MEGA version 6.0 (23) and models for analysis according to the best fit substitution model (TN93 + gamma + invariate for L segments, general time reversible + gamma + invariant for M segments, and T92 + gamma for S segments). We assessed support for topologies by bootstrapping for 1,000 iterations. The prototype strain used, SEOV 80-39, was isolated from R. norvegicus rats captured in Seoul in 1980.
Retrospective Analysis of HFRS Patient Specimens
We found that specimens collected in 2002 from 6 HFRS patients were positive for SEOV by ELISA (J.-W. Song and H. Kariwa, unpub. data). We confirmed that the HFRS specimens were serologically positive for SEOV by IFA (Table 1). Titers of SEOV-specific antibody ranged from 1:128 to 1:4,096. Reverse transcription PCR detected the partial sequence of L segment (nt 2946–3335) from 2 HFRS patients (Hu02-180 and Hu02-258).
Epidemiologic Surveillance of R. norvegicus Rats
We collected 1,269 R. norvegicus rats in urban HFRS-endemic areas in South Korea, including the city of Seoul (1,226/1,269) and Gyeonggi (40/1,269), Gangwon (1/1,269), and Jeollanam (2/1,269) Provinces (Table 2). A total of 76 (6.2%) of 1,226 rats collected in Seoul were serologically positive for SEOV. However, we found IgG against SEOV in only 1 (2.3%) of 43 rats collected from the other areas, including Gyeonggi, Gangwon, and Jeollanam Provinces. We detected SEOV RNA in 13 (16.9%) of 77 seropositive R. norvegicus rats. Serologic prevalence of SEOV in male rats (7.5%, 43/576) was not significantly different from that in female rats (5.0%, 34/684) (p = 0.0763 by χ2 test). Serologic prevalence of SEOV in rats by weight (age) was 6.1% (21/342) in those weighing <50 g, 5.9% (22/374) in those weighing 51–100 g, 5.8% (30/521) in those weighing 101–200 g, and 13.8% (4/29) in those weighing 201–300 g. Seasonal prevalence of SEOV infection in rats was 5.8% (11 of 190) in spring (March–May), 4.4% (19/433) in summer (June–August), 6.4% (27/420) in fall (September–November), and 10.0% (19/190) in winter (December–February).
SEOV RNA Loads in Tissues from Seropositive R. norvegicus Rats
To measure viral load of SEOV RNA in R. norvegicus rats, we performed real-time qPCR for seropositive samples from lungs, livers, kidneys, and spleens (Figure 1). Viral load for SEOV showed ranges from tissues of 5 rats (Rn02-15, Rn10-134, Rn10-145, Rn11-44, and Rn11-53) that were positive by serologic and molecular screening (IFA+ PCR+). Rat Rn10-145 showed the highest amount of SEOV RNA in all tissues, followed by rats Rn02-15 and Rn10-134. Rat Rn11-44 showed the highest amount of SEOV RNA in all tissues except liver. Rat Rn11-53 showed the highest amount of SEOV RNA load in lung tissues, but virus RNA was not detectable in liver, kidney, and spleen tissues.
Multiplex PCR–Based NGS for Retrospective HFRS Patient and R. norvegicus Rat Specimens
We determined viral loads for HFRS patient specimens by using real-time qPCR. Cycle threshold (Ct) values ranged from 27.5 to 36.8 (Table 3). To perform multiplex PCR–based NGS for SEOV, we designed multiplex PCR primers to amplify every 150-bp sequence for the entire SEOV tripartite genome. We recovered genomic sequences of SEOV from 6 SEOV-positive patient samples. We sequenced human sample Hu02-258, which showed the highest viral load (lowest Ct value), for 99.6% of the L segment, 99.7% of the M segment, and 91.6% of the S segment. Recovery rates for SEOV genomic sequences from samples Hu02-180 and Hu02-529 showed a correlation with viral loads. Samples Hu02-112, Hu02-294, and Hu02-668 showed high recovery rates of SEOV S and M segments despite lower viral loads (highest Ct values). However, the L segment showed relatively low coverages (85.0% for Hu02-180, 68.2% for Hu02-294, and 72.7% for Hu02-668).
Using total RNA extracted from rat lung tissues, we determined viral loads by using real-time qPCR. Ct values ranged from 16.1 to 27.6. We applied multiplex PCR–based NGS for whole-genome sequencing of 4 SEOV strains in the IFA+ PCR+ rats captured in South Korea during 2000–2016. Coverage of genomic sequences of SEOV was 99.1%–99.7% for L segments, 99.2%–99.7% for M segments, and 98.3%–99.4% for S segments. We observed a correlation between Ct values and multiplex PCR–based NGS coverages (Technical Appendix 2). Whole-genome sequences from Rn10-134, Rn10-145, Rn11-44, and Rn11-53 were obtained with termini sequences of 3′ and 5′ ends. SEOV sequences were deposited in GenBank (accession nos. MF149938–MF149957).
Global Diversity of SEOV
We generated phylogenetic trees by using nearly complete genome sequences of SEOV and the maximum-likelihood method. Phylogenetic analysis demonstrated distinct phylogenetic groups (groups A–F). Group A contained SEOV strains from northeastern and southeastern China and an SEOV strain from North Korea. Group B contained SEOV strains from Southeast Asia (Singapore and Vietnam) and France. Group C contained SEOV strains from South Korea and Japan and SEOV strains Tchoupitoulas from Louisiana in the United States. Group D contained an EOV strain from Jiangxi and Hubei Provinces in southeastern China. Group E contained strains from the United Kingdom and the United States (New York, NY, and Baltimore, MD). Group F contained SEOV strains from mountainous areas in southeastern China.
We obtained 9 genome sequences of SEOV S segments from HFRS patients and R. norvegicus rats. Phylogenetic analysis of SEOV S segments showed that group A formed a monophyletic lineage with group D (Figure 2). Group C genetically clustered with group E. The phylogeny of group B was distinct from those of groups A, C, D, and E. Group F from mountainous areas in China formed a lineage that was independent from the other groups obtained from rats collected in urban areas.
We obtained 6 genome sequences of SEOV M segments from HFRS patients and R. norvegicus rats (Figure 3). Phylogenetic analysis of SEOV M segments showed distinct phylogenetic clusters (groups A–F). These phylogenetic patterns showed that M segments of SEOV had genetic heterogeneity when compared with S segments.
We obtained and phylogenetically analyzed 5 SEOV L segments (Figure 4). The SEOV L segment from an HFRS patient and R. norvegicus rats captured in South Korea clustered to form a monophyletic group with SEOV 80-39. SEOV strains from China belonged to a genetic lineage with SEOV DPRK08 from North Korea. SEOV strains from the United Kingdom and Baltimore formed a close phylogenetic group. SEOV IR33 and IR473 obtained from laboratory outbreaks in the United Kingdom were independent from other SEOV strains.
NGS is a robust tool for obtaining extensive genetic information and completing whole-genome sequences (18). However, molecular enrichment plays a critical role in amplification of pathogen genome sequences from clinical or animal specimens. Our previous study showed recovery of nearly whole-genomic sequences of HTNV from HFRS military patients by using virus-targeted molecular enrichment (19).
In this study, whole-genomic sequencing of SEOV, an etiologic agent of mild HFRS worldwide, was applied to samples from retrospective HFRS patients and seropositive R. norvegicus rats by using multiplex PCR–based NGS. Nearly whole-genome sequences of SEOV tripartite RNA, on the basis of SEOV 80-39 (prototype strain), corresponded to viral loads of patient serum samples and rat lung tissues. Phylogenetic analyses of the genome sequence of SEOV tripartite RNA supported worldwide distributions of SEOV and identified 6 genetic lineage groups. Group A contained SEOV strains from northeastern and southeastern China and North Korea. Group B contained SEOV strains from Singapore and Vietnam in Southeast Asia and Lyon in France. Group C contained SEOV strains originating primarily in South Korea and Japan and an SEOV strain from Louisiana in the United States. Group D consisted of SEOV strains from southeastern China, including Jiangxi and Hubei Provinces. Group E contained SEOV strains from the United Kingdom and eastern United States (New York and Baltimore) and formed a monophyletic lineage. Group F contained SEOV strains from mountainous areas in southeastern China (24).
SEOV originated in China and spread worldwide during movement of rats coincidently with human activities (e.g., commercial trade, travel, and migration by railways and through seaports) (24). The close genetic relationship of SEOV in South Korea and Japan was probably caused by geographic distance and historical activities (e.g., commerce and occupation by Japanese forces). The genetic lineage containing strains from Southeast Asia and France might have originated during colonization or on trade routes that extended distribution of SEOV-infected rats (25). Recently, SEOV outbreaks have been reported in the United Kingdom and United States. Clinical cases showed that SEOV infections were identified among pet owners, breeders, and distributors (26). The genetic relationship of SEOV between counties probably reflects movement of rats associated with the animal pet market.
The prevalence of hantaviruses (e.g., HTNV and Imjin virus [MJNV]) in natural reservoir hosts has showed sex- and weight (age)–specific differences (27,28). However, in our study, the incidence of SEOV in R. norvegicus rats was not dependent on sex and weight (age). Epidemiologic differences in hantavirus infections between A. agrarius and R. norvegicus rats might be, in part, caused by ecologic differences, reservoir host distributions, and behavior (e.g., association with humans) (29). Seasonal circulation of SEOV infection was maintained over 1 year, suggesting an enzootic infectious cycle. These observations might suggest that preventive strategies for disease risk mitigation focus on limits of rat populations all year.
Our previous study demonstrated differential amounts of HTNV RNA in lung, kidney, liver, and spleen tissues of rodents collected in areas in which HFRS is prevalent (30). In addition, the genomic RNA load of MJNV, a shrewborne hantavirus, showed various patterns in different tissues in nature (28). IFA+ PCR+ shrews showed high and various loads of MJNV RNA in all tissues. MJNV RNA from IFA– PCR+ shrews was detected in lung but not in kidney, liver, or spleen tissues, indicating an early phase of infection before MJNV-specific IgG was produced (31,32). In our study, rats Rn02-15, Rn10-134, and Rn10-145 showed various amounts of SEOV RNA in all tissues. Rat Rn11-44 had high levels of SEOV RNA in all tissues except the liver. Virus RNA in rat Rn11-53 might reflect the early phase of SEOV infections because of highest viral load in lung tissues but not other tissues. Patterns of SEOV RNA loads might indicate systemic infections in nature and active circulation of virus among rat populations in urban HFRS-endemic areas.
Diversity of virus genomes results from genomic variation or exchanges (33). RNA viruses show high mutation rates caused by deficiencies in proofreading by virus polymerases. Genomic variation also results from a mechanism of host immune evasion (34,35). Genetic exchanges, such as reassortment and recombination, lead to the generation of divergent virus progeny (36). Our previous studies identified reassortment and recombination of hantaviruses, including HTNV and MJNV, in nature (19,28,37). Using nearly complete sequences of SEOV S, M, and L segments, phylogenetic analyses demonstrated that S segments of group A SEOVs formed a cluster with those of group D SEOVs and that L and M segments of group A SEOVs showed a close phylogenetic relationship with those of group B SEOVs. The S segment of group C SEOVs grouped phylogenetically with group E SEOVs. However, L and M segments of group C SEOVs formed a distant genetic cluster from those of group E SEOVs. Phylogenetic analysis of SEOV S segments showed a differential pattern from that of SEOV M segments, indicating a genome organization compatible with genetic exchanges in nature. To clarify genetic events among SEOV worldwide, whole-genome sequences of the SEOV L segment need to be investigated. Application of multiplex PCR–based NGS will be useful in elucidating phylogenetic patterns of the SEOV L segment.
In conclusion, this epidemiologic survey of R. norvegicus rats in urban HFRS-endemic areas of South Korea identified the prevalence and distribution of SEOV. We applied multiplex PCR–based NGS to whole-genome sequencing of SEOV tripartite RNA from retrospective serum samples from HFRS patients and rat tissues. Phylogenetic analyses demonstrated the global distribution and genetic diversity of SEOV on the basis of nearly complete genome sequences. This study provides useful information for SEOV-based surveillance, disease risk assessment, and mitigation against hantavirus outbreaks.
Dr. Won-Keun Kim is a virologist and research instructor at the College of Medicine, Korea University, Seoul, South Korea. His research interests include next-generation sequencing, hantaviruses, and virus−host interactions.
We thank Charles Hong for providing support; Ji Hye Kim for providing experiment support; the Pest Management staff, US Army Garrison, Yongsan, for collecting rats; American soldiers for collecting rodents at US Army training sites/installations; and Ki-Joon Song for providing retrospective HFRS patient serum samples.
This study was supported by the Agency for Defense Development (South Korea) (grant UD160022ID), the National Research Foundation (South Korea) (grant NRF-2017M3A9E4061992), and the Armed Forces Health Surveillance Branch−Global Emerging Infections Surveillance and Response System (Silver Spring, MD, USA).
- Kruger DH, Figueiredo LT, Song JW, Klempa B. Hantaviruses: globally emerging pathogens. J Clin Virol. 2015;64:128–36.
- Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 2010;23:412–41.
- Jiang H, Du H, Wang LM, Wang PZ, Bai XF. Hemorrhagic fever with renal syndrome: pathogenesis and clinical picture. Front Cell Infect Microbiol. 2016;6:1.
- Vaheri A, Strandin T, Hepojoki J, Sironen T, Henttonen H, Mäkelä S, et al. Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol. 2013;11:539–50.
- Lee HW, Baek LJ, Johnson KM. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis. 1982;146:638–44.
- Wang H, Yoshimatsu K, Ebihara H, Ogino M, Araki K, Kariwa H, et al. Genetic diversity of hantaviruses isolated in china and characterization of novel hantaviruses isolated from Niviventer confucianus and Rattus rattus. Virology. 2000;278:332–45.
- Reynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, et al. Seoul virus infection in humans, France, 2014−2016. Emerg Infect Dis. 2017;23:973–7.
- Zhang YZ, Zou Y, Fu ZF, Plyusnin A. Hantavirus infections in humans and animals, China. Emerg Infect Dis. 2010;16:1195–203.
- Truong TT, Yoshimatsu K, Araki K, Lee BH, Nakamura I, Endo R, et al. Molecular epidemiological and serological studies of hantavirus infection in northern Vietnam. J Vet Med Sci. 2009;71:1357–63.
- Jameson LJ, Logue CH, Atkinson B, Baker N, Galbraith SE, Carroll MW, et al. The continued emergence of hantaviruses: isolation of a Seoul virus implicated in human disease, United Kingdom, October 2012. Euro Surveill. 2013;18:4–7.
- Woods C, Palekar R, Kim P, Blythe D, de Senarclens O, Feldman K, et al. Domestically acquired seoul virus causing hemorrhagic fever with renal syndrome—Maryland, 2008. Clin Infect Dis. 2009;49:e109–12.
- Witkowski PT, Klempa B, Ithete NL, Auste B, Mfune JK, Hoveka J, et al. Hantaviruses in Africa. Virus Res. 2014;187:34–42.
- Kim YS, Ahn C, Han JS, Kim S, Lee JS, Lee PW. Hemorrhagic fever with renal syndrome caused by the Seoul virus. Nephron. 1995;71:419–27.
- Taori SK, Jameson LJ, Campbell A, Drew PJ, McCarthy ND, Hart J, et al. UK hantavirus, renal failure, and pet rats. Lancet. 2013;381:1070.
- Centers for Disease Control and Prevention. Multi-state outbreak of Seoul virus. March 14, 2017 [cited 2017 Nov 18]. https://www.cdc.gov/hantavirus/outbreaks/seoul-virus/
- Fill MA, Mullins H, May AS, Henderson H, Brown SM, Chiang CF, et al. Notes from the field: multiple cases of Seoul virus infection in a household with infected pet rats—Tennessee, December 2016−April 2017. MMWR Morb Mortal Wkly Rep. 2017;66:1081–2.
- Firth C, Bhat M, Firth MA, Williams SH, Frye MJ, Simmonds P, et al. Detection of zoonotic pathogens and characterization of novel viruses carried by commensal Rattus norvegicus in New York City. MBio. 2014;5:e01933–14.
- Houldcroft CJ, Beale MA, Breuer J. Clinical and biological insights from viral genome sequencing. Nat Rev Microbiol. 2017;15:183–92.
- Kim WK, Kim JA, Song DH, Lee D, Kim YC, Lee SY, et al. Phylogeographic analysis of hemorrhagic fever with renal syndrome patients using multiplex PCR-based next generation sequencing. Sci Rep. 2016;6:26017.
- Klempa B, Fichet-Calvet E, Lecompte E, Auste B, Aniskin V, Meisel H, et al. Hantavirus in African wood mouse, Guinea. Emerg Infect Dis. 2006;12:838–40.
- Li PE, Lo CC, Anderson JJ, Davenport KW, Bishop-Lilly KA, Xu Y, et al. Enabling the democratization of the genomics revolution with a fully integrated web-based bioinformatics platform. Nucleic Acids Res. 2017;45:67–80.
- Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7.
- Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30:2725–9.
- Lin XD, Guo WP, Wang W, Zou Y, Hao ZY, Zhou DJ, et al. Migration of Norway rats resulted in the worldwide distribution of Seoul hantavirus today. J Virol. 2012;86:972–81.
- Heyman P, Plyusnina A, Berny P, Cochez C, Artois M, Zizi M, et al. Seoul hantavirus in Europe: first demonstration of the virus genome in wild Rattus norvegicus captured in France. Eur J Clin Microbiol Infect Dis. 2004;23:711–7.
- Outbreak of Seoul virus in humans linked to pet rats. J Am Vet Med Assoc. 2017;250:592 [cited 2017 Nov 19]. https://www.avma.org/News/JAVMANews/Pages/170315g.aspx
- Klein TA, Kim HC, Chong ST, Kim JA, Lee SY, Kim WK, et al. Hantaan virus surveillance targeting small mammals at nightmare range, a high elevation military training area, Gyeonggi Province, Republic of Korea. PLoS One. 2015;10:e0118483.
- Lee SH, Kim WK, No JS, Kim JA, Kim JI, Gu SH, et al. Dynamic circulation and genetic exchange of a shrew-borne hantavirus, Imjin virus, in the Republic of Korea. Sci Rep. 2017;7:44369.
- Zeier M, Handermann M, Bahr U, Rensch B, Müller S, Kehm R, et al. New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention—a review. Virus Genes. 2005;30:157–80.
- No JS, Kim WK, Kim JA, Lee SH, Lee SY, Kim JH, et al. Detection of Hantaan virus RNA from anti-Hantaan virus IgG seronegative rodents in an area of high endemicity in Republic of Korea. Microbiol Immunol. 2016;60:268–71.
- Lee PW, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Pathogenesis of experimental Hantaan virus infection in laboratory rats. Arch Virol. 1986;88:57–66.
- Easterbrook JD, Klein SL. Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog. 2008;4:e1000172.
- Duffy S, Shackelton LA, Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet. 2008;9:267–76.
- Vijaykrishna D, Mukerji R, Smith GJ. RNA virus reassortment: an evolutionary mechanism for host jumps and immune evasion. PLoS Pathog. 2015;11:e1004902.
- Doud MB, Hensley SE, Bloom JD. Complete mapping of viral escape from neutralizing antibodies. PLoS Pathog. 2017;13:e1006271.
- McDonald SM, Nelson MI, Turner PE, Patton JT. Reassortment in segmented RNA viruses: mechanisms and outcomes. Nat Rev Microbiol. 2016;14:448–60.
- Kim JA, Kim WK, No JS, Lee SH, Lee SY, Kim JH, et al. Genetic diversity and reassortment of Hantaan virus tripartite RNA genomes in nature, the Republic of Korea. PLoS Negl Trop Dis. 2016;10:e0004650.
Technical AppendicesCite This Article
1These authors contributed equally to this article.
- Page created: January 17, 2018
- Page last updated: January 17, 2018
- Page last reviewed: January 17, 2018
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)